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Abstract 
Background  Pin tract infection is one of the most common complications of external fixation. 
We developed techniques to coat titanium implant surfaces with iodine. This study clinically 
evaluated infection preventive effects and biological safety of iodine-coated external fixation pins. 
Patients and methods  Iodine-supported pins were placed in 39 limbs of 38 patients. The mean 
age of the patients was 33.6 years. Twenty-six patients were men and 12 were women. In all 
patients, the iodine-coated pins were used to prevent infection. There were 476 pin insertion sites. 
Pin sites were classified according to the Checketts-Otterburns classification (Grade1~6). White 
blood cells (WBC) and C-reactive protein (CRP) were measured pre- and post-operatively in all 
patients. To confirm whether iodine from the implant affected physiological functions, thyroid 
hormone levels in the blood were examined. The change over time for the amount of iodine 
deposited in the body was calculated from the removed pins. 
Results  External fixation was used for a mean duration of 6 months. Grade 1 infection was found 
in 2.5% of patients, and grade 2 infection in 1.1%. There was no patient with infection of grade 3 
or higher. Median WBC levels were in the normal range and median CRP levels returned to <0.3 
mg/dl within 3 weeks after surgery. Abnormalities of thyroid gland function were not detected. 
The amount of iodine was maintained for a long time with approximately 40% remaining after 1 
year. 
Conclusions  Iodine-supported titanium pins were able to decrease pin tract infection rate and had 
no impact on thyroid function. These results suggest that iodine-coated titanium pins are 
biologically safe and excellent in prevention of pin tract infections. 
 
Introduction 
Pin tract infection is one of the most common complications of external fixation. This type of 
infection has been reported to occur in over 50% of patients after pin insertion [1, 2]. If the 
infection does not progress beyond superficial infection, it does not become a major problem. If 
the infection reaches a deeper area, then the pins can loosen and the condition can worsen to 
osteomyelitis. Therefore, prevention of infection is important. 
There have been reports on various efforts to reduce the incidence of implant-associated 
infection. Such efforts included the development of antibacterial pins made of titanium-copper 
alloys [3] and metal surface treatment involving silver, antibacterial agents, hyaluronic acid, and 
albumin [4-8]. We have been creating an oxide film on titanium surfaces by anodization and have 
been developing techniques to impregnate this multiple porous film with the antiseptic properties 
of iodine (Fig. 1) [9]. This coating can be applied on various types of titanium implants, and a 
clinical trial has been ongoing since 2008 [10]. 
In this study, clinical evaluation was performed on the effectiveness and safety of titanium 
external fixation pins coated with iodine (Fig. 2). 
 
Patients and Methods  
This prospective cohort study was approved by the institutional review boards at our institution. 
The subjects were 38 patients who had undergone external fixation using iodine-coated titanium 
pins. Informed consent was obtained from patients and family members. The pins were placed in 
39 lower limbs. The patients were 26 men (26 limbs) and 12 women (13 limbs). The mean age of 
the patients was 33.6 years (range, 5-64 years). The diagnoses included 20 cases of limb 
deformity and shortening, 8 cases of pseudoarthrosis (4 cases of congenital pseudoarthrosis of the 
tibia [CPT]), 6 cases of fracture, 3 cases of equinus foot, and 2 cases of tumor. The operative 
procedure was gradual deformity correction in 17 limbs, fixation for fracture or pseudoarthrosis 
in 13, limb lengthening in 5 and bone transport in 4. There were 476 pin insertion sites: 46 sites in 
the femur, 335 sites in the lower leg, and 95 sites in the foot. Pin site care consisted of only daily 
showers. 
The infection was evaluated using the Checketts- Otterburn classification [11]. The severity was 
classified into grades 1 to 6 based on erythema, pain, discharge, and plain x-ray findings (Table 
1). Grades 1-3 were superficial infection and grades 4-6 were deep infection. In addition, serum 
white blood cells (WBC) and C-reactive protein (CRP) were measured before surgery and 
periodically after surgery. 
The biological safety of iodine was evaluated by measuring serum thyroid-stimulating hormone 
(TSH), free triiodothyronine (FT3), and free thyroxine (FT4). 
Measurements were made to examine the changes over time in the amount of iodine remaining 
on pins (amount of impregnated iodine). These measurements were made on pins removed from 
28 patients (116 pins) when the treatment goals were reached.  
 
Statistical analysis 
The differences of pin tract infection rate by operative procedure were analyzed by use of the chi-
square test, with P < 0.05 for the difference in values considered as being significant. 
 
Results 
External fixation was used for a mean duration of 6 months, and all patients achieved their 
treatment goals. Twelve patients (12 limbs, 17 sites) had pin tract infection. The infection rate 
was 3.6% (17/476 sites), and all patients had superficial infection. Infection did not go beyond 
grade 1 in 8 limbs of 8 patients (12 sites) (2.5%). Infection was grade 2 in 4 limbs of 4 patients (5 
sites) (1.1%). There was no patient with infection of grade 3 or higher. The mean time at which 
infection occurred was 7.2 weeks (range, 3~12 weeks). Two of the 12 patients had reinfection of 
the pin tract. All cases of infection were resolved by treatment with oral antibiotics alone. No 
patient had loose or broken pins. The operative procedures in which pin tract infections occurred 
were 5 deformity corrections (7 sites), 4 fixations (6 sites), 2 bone transport (3 sites) and 1 limb 
lengthening (1 site) procedures. There was infection in 4.4% of the thigh pin insertion sites (2/46) 
and 4.5% of the leg pin insertion sites (15/335). 
The WBCs at 1, 2, 3, 4, 6, 8, and 12 weeks and 6 months after surgery were: 7,230±920/µl, 
6,970±750/µl, 6,720±570/µl, 5,790±370/µl, 5,830±280/µl, 6,320±480/µl, 6,680±450/µl, and 
6,230±660/µl, respectively. All values were under 8,000/µl. The CRP levels were 1.99±0.62 
mg/dl, 0.89±0.34 mg/dl, 0.33±0.13 mg/dl, 0.42±0.17 mg/dl, 0.33±0.10 mg/dl, 0.47±0.16 mg/dl, 
0.42±0.18 mg/dl, and 0.11±0.03 mg/dl, respectively. The values for all patients normalized to 0.5 
mg/dl or less within 3 weeks after surgery. 
The levels of thyroid hormones TSH, FT3, and FT4 were 1.81±0.28 µIU/ml, 2.76±0.14 pg/ml, 
and 1.27±0.06 ng/dl, respectively, at 2 weeks after surgery; 1.92±0.23 µIU/ml, 2.85±0.11 pg/ml, 
and 1.22±0.06 ng/dl at 4 weeks after surgery; 1.93±0.26 µIU/ml, 2.81±0.13 pg/ml, and 1.15±0.06 
ng/dl at 8 weeks after surgery; 1.90±0.31 µIU/ml, 3.08±0.13 pg/ml, and 1.24±0.05 ng/dl at 12 
weeks after surgery; and 1.98±0.52 µIU/ml, 2.93±0.11 pg/ml, and 1.26±0.04 ng/dl at 6 months 
after surgery. There was no patient with abnormal values. 
In the removed pins, the mean percentages of iodine remaining were 41.6% of the original 
amount at 0-4 months, 49.8% at 5-8 months, and 42.0% at 9-12 months (Table 2). 
 
Discussion 
In external fixation, it has been previously reported that infection occurs in 50% or more of the 
pin insertion sites when no preventive measures are taken [1, 2]. In our study, pin tract infection 
occurred in 12 limbs of 12 patients, 3.6% of the pin insertion sites (17/476 sites). Iodine-
supported titanium pins may reduce the rate of pin tract infection. 
All patients in our study had superficial infection of severity grades 1-2. In previous reports, 
superficial infection was seen in much higher percentages of patients at 16-74.1% [12-14]. In our 
patients, WBC was normal and CRP normalized 3 weeks after surgery. Thus, hematological 
findings also showed that iodine-coated pins had a high ability to control infection at the insertion 
sites (Fig. 3). Lee et al. [15] reported that pin tract infection rate could be reduced using 
polyhexamethylene biguanide-impregnated gauze. If iodine-supported pins are used together with 
polyhexamethylene biguanide-impregnated gauze, the infection rate may be further reduced. 
Iodine-coated pins prevent not only surface infection, but also deep infection, because the 
antimicrobial coating with iodine covers the whole pin. 
Basic research has been conducted regarding various metal surface treatments to reduce the rate 
of implant-associated infection [3-8]. Masse et al. [16] used silver-coated pins for external 
fixation and reported an infection rate of 30%. Other studies have reported on silver-coated pins 
for external fixation [17, 18]. However, some studies have raised concerns over clinical toxicity 
of silver coating [15, 19]. 
For an antibacterial coating, Popat et al. [20] fabricated nanotubes on titanium surfaces by 
oxidation. They reported on the techniques, including loading the nanotubes with the antibiotic 
gentamicin. Another report described prevention of pin tract infection by fitting gentamicin-
coated sleeves over the pins [21]. These studies were basic research and not clinical trials. 
Antibacterial agents have disadvantages. The development of resistant bacteria is unavoidable, 
and the effectiveness of these agents will not last long term. 
Since 2005, we have been developing techniques to treat titanium surfaces with iodine using a 
special method [9]. Iodine has been used widely in clinical practice as an antiseptic and contrast 
medium. It is a substance whose safety has been confirmed. In addition, iodine has a broad 
antimicrobial spectrum against common bacteria, fungi, and common viruses. Another advantage 
is that it does not cause resistant bacteria. 
The relationship between operative procedure and pin tract infection was investigated. In 
patients with superficial infection of pin site, the operative procedure was deformity correction in 
5 patients (7 sites), fixation in 4 patients (6 sites), bone transport in 2 patients (3 sites), and limb 
lengthening in 1 patient (1 site). Thus, infection rate was 3.3% (7/215 sites) in deformity 
correction, 4.0% (6/149 sites) in fixation, 7.0% (3/43 sites) in bone transport and 1.5% (1/69 
sites) in limb lengthening. There were no obvious differences by operative procedure (P=0.47). 
Additional factors that may contribute to pin tract infection include the thickness of the soft 
tissue mantle between the skin and bone, with anatomical areas with thicker soft tissue envelopes, 
such as the thigh, associated with higher infection rates [22]. In our study, there were 17 sites 
with superficial infection, of which 2 sites were in the femur (4.4% of the femoral pin insertion 
sites) and 15 sites were in the lower leg (4.5% of the lower leg pin insertion sites). Thus, there 
was no difference in the infection rates by site. These results indicate that iodine coating does not 
affect the infection rate, which is influenced by the amount of soft tissue at the pin insertion. This 
may be due to the antimicrobial efficacy of iodine coating.  
Our study examined the safety of iodine-coated pins. There was no patient with abnormal 
thyroid hormone levels after surgery. Iodine is an essential trace element in the human body and 
exists in our body in thyroid hormones. It is thought to have low toxicity in the body. 
In our study, no loosening around the pins was observed radiographically during treatment. Thus, 
it was determined that there was no local toxicity of iodine. 
Our study also examined the duration of the sustained effect by measuring the amount of 
remaining iodine in the removed pins. The mean percentage of remaining iodine was 41.6±17.3% 
at 0-4 months, 49.8±19.9% at 5-8 months, and 42.0±16.7% at 9-12 months. Although the amount 
of iodine decreased to 40~50% at an early stage comparatively, it was retained for one year. The 
reason why more iodine remained in patients with the long-term fixation is unclear. However, we 
speculate that the amount of remaining iodine depends on the environment of the pin sites or 
individual variability of the patients. Namely, the degree of exudate around pin tracts would 
affect the release of iodine on the surface. The duration of the sustained effect was better for 
iodine-coated pins than for antibacterial agents. Thus, our findings suggest that iodine-coated pins 
are effective in prevention of delayed-onset infection. 
Iodine coating might also be applicable to other titanium implants for orthopedic surgery, 
implants in dental and oral regions, heart valve prostheses, cochlear implants, and catheters. 
Iodine-supported pins for external fixation have good biological safety and tissue compatibility. 
These pins are clinically useful to control infection at a pin insertion site. 
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Figure Captions 
 
Figure 1： Electron micrograph of the oxide layer 
a, More than 100,000 pores/mm2 
                  b, Magnified image 
 
Figure 2：Iodine-coated pins  
 
Figure 3：Condition around pins at six months 
 
Table 1: Checketts- Otterburn  classification of pin site infections 
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